Lansoprazole/Domperidone

兰索拉唑/多潘立酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLansoprazole/Domperidone
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionProton pump inhibitorsDopamine D2 receptor antagonists
TargetsProton pumpDopamine D2 receptor
Therapy Area/IndicationsGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTurkey
CombinationsYes LansoprazoleDomperidone
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeutec Ar-Ge San Ve Tic A.Ş
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsGastroesophageal Reflux
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A